Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/13kRbp4WgvI.

TTOO stock - or T2 Biosystem stock - is enjoying immense popularity for reasons we can't discern. Whatever technology platform they might have is completely irrelevant when they can barely eek by a positive gross margin. Should this $15 million market cap company default on the $50 million in notes payable on their balance sheet, the lender can then take full control of nearly all their assets including intellectual property. Since raising more debt isn't an option, it's they may choose to sell stock. The problem is, they just gave away over 90% of the company in offerings while diluting existing shareholders into oblivion. Even after those dilutive raises, they still don't even have enough cash to get through the next few quarters. Sounds absolutely horrible, which is exactly why the meme stock types are being attracted to it. They seem to love companies that ride on the edge of insolvency. If we had to assign a price target to $TTOO stock it would be zero. In case you need further proof that T2 Biosystems might be one of the most poorly run companies ever, just look at how much management is getting paid. Do they really deserve to be making millions while TTOO shareholders are slowly ground to a pulp?

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/pIGKVNGyYfo.

How to calculate market size is an art more than a science as you'll get a dozen different answers from a dozen different sources, many of which shouldn't be taken seriously. Investors want to know the total addressable market or TAM because it indicates how much opportunity for growth there is. Unfortunately, many companies use TAM incorrectly when they should be looking at SAM and SOM - serviceable addressable market and serviceable obtainable market - which more accurately reflect the opportunity a company can capture given constraints like product functionality or geography. Be careful about defining market share as a percentage of TAM. Instead, market shares are the percentage of TAM captured for any given company. We give some examples of how market size estimates vary so widely and look at how breaking a market opportunity down into components makes it easier to understand.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/RU2gWBel18Q.

How to read a 10-K quickly requires a lot of experience, but they're so accessible that anyone can do it. Our tutorial on how to read a 10-K annual report used an interesting life sciences company called Novocure as an example. Using nothing but the latest 10-K report, we show you how to quickly and efficiently analyze the information to find out what the company does. We quickly hone in on estimates of the total addressable market and conclude that Novocure stock isn't one we're interested in. For investors with more risk tolerance, NVCR stock offers future promise when other indications allow them to expand the TAM about 14X. If you've been wondering how to read an annual report, or how to find a US 10-K annual report filing, then this tutorial will help you get started.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/TxkgwgZrzwo.

When to sell stocks is a more important decision than when to buy them because it's when you lock in profits or losses. Most newbies run into problems because they buy stocks based on what other people think. Most of these supposed "stock tips" are useless because they say nothing about the most important decision an investor needs to make - when to sell stocks? For long-term investments, these decisions become even more difficult as no investor likes to leave money on the table. That's why buying stocks you're willing to hold forever is the best way to sleep well at night. IF you buy the highest quality companies with business that have proven to be resilient over time, there will be few reasons to ever sell aside from rebalancing. There are three reasons we would sell any tech stock and one reason only that would drive us to sell a dividend growth stock.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/D5HzPQ4skqw.

Nanox stock isn't just wildly overvalued, it suffers from execution problems and has red flags galore. The last time we checked in was three years ago and we didn't miss much. They acquired a few firms and the result is a trickling of revenues from selling something for less than it costs to produce. There's an outstanding inquiry by the SEC, not to mention several class action lawsuits that hopefully get settled. The last FDA approval we saw several years ago was supposed to result in sales, but now we're told it will take another three years for the 15,000 machines we keep hearing about to be deployed. In the meantime, they're shipping a few demonstration units off to places like Ghana and Nigeria while revenues from their core product offering remain at zero. With all the great medical device companies out there, we're at a loss as to why anyone would want to waste their time looking at a company that's been developing a technology for a year, yet hasn't been able to monetize it yet. For those of you who choose to dabble, we've provided some price targets based on a valuation that you're not going to like.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/rVYvaJQCsAA.

Our guide on how to invest in stocks for beginners starts with a holistic look at what you're trying to accomplish. Yeah yeah, you want to make money, don't we all, but if you're trying to do that by investing in one or two stocks then you're in for a world of hurt. Start by taking a holistic look at all your assets. Oh, you don't have any assets, well then start by putting together a portfolio of stocks you'd like to own - at least 20. Don't have the time? We'll do it for you, or you can just invest in a few ETFs every month and start to accumulate wealth that way. If you do have a lump sum of wealth to invest, don't try and time the markets. Use dollar cost averaging to accumulate slowly over time and you'll sleep much better at night. Investing in stocks for beginners can be never wracking, or it can be a great learning experience on your way to becoming a great investor. Accumulating wealth in the stock market takes time. There are no shortcuts, and countless landmines can erode the money you've worked hard to save. Our honest guide on how to buy stocks for beginners helps you navigate all the complexity and rubbish.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Signup now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/_F2YU2hYWDQ.

Financial dividend stocks offer plenty of selection for dividend growth investors - from insurance companies to asset managers. We took a list of nine dividend champions in the financial sector and narrowed it down to the top four stocks. To find the best one, we considered numerous factors including sub-sector, yield, payout ratios, dividend growth, size, and how easy the company would be for your average retail investor to understand and monitor. Our four finalists - SPGI, AFL, TROW, and BEN all scored high across all factors, but only one could claim the title of the best financial dividend stock out there. If you're looking for top dividend champions across all eleven sectors, then financials is a place to look for some quality names that are easy to follow and well diversified to ensure consistency in dividend growth over time. The special dividends coming from asset managers like TROW and BEN are just an added perk.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Signup now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/-wkEwN18BYo.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Signup now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/fANC31OHBbc.

Tech dividend stock is an oxymoron. That's because any tech company that's experiencing strong growth ought to be ploughing profits back into the company instead of paying dividends. Still, there's a handful of tech dividend stocks that have managed to achieve the holy grail of dividend stocks - dividend champion status, which means they've managed to increase their dividend for at least 25 consecutive years. We identified ad ranked four technology stocks that have managed this feat and ranked them according to seven factors such as yield, dividend growth, size, and number of years increasing dividends. If you're looking for top dividend tech stocks - and we don't know why you would be - then this is the video to watch. Fair disclosure: we're invested in two of these tech dividend stocks. Which ones do you say? Well little Johnny, you'll just have to watch the video.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Signup now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/nY8G13NuXlo.

American Superconductor stock - or AMSC stock - soared on the back of news that some researchers out of South Korea invented a material that demonstrates superconductivity (no resistance to electricity) at room temperature and ambient pressure. That claim hasn't been formally validated yet. Even if it were to be, they still haven't proven the material can be produced in a cost-effective manner and turned into commercially viable devices. Not to mention, this could be simple a step towards a breakthrough in the future, which raises the question of intellectual property, which is yet another unknown that's pointless to pursue. For those investors who think $AMSC is at the forefront of this work, think again. The only relationship between the two is a) the name (what all the degens latch onto) and b) the fact that AMSC transmits power and could benefit from the breakthrough, or be made obsolete. We just don't know enough yet. Competent investors know there's just one thing to do right now. Hurry up and wait.